P
arkinson disease is a neurodegenerative disease characterized by bradykinesia, rigidity, resting tremor, and postural instability 1 . With disease progression, postural instability increases, often leading to falls 2, 3 . While dopaminergic therapy improves tremor and rigidity, symptoms such as bradykinesia, freezing when walking, and impaired balance may remain, resulting in an increased risk of falls and injury 4, 5 . People with Parkinson disease are particularly susceptible to hip fractures [5] [6] [7] , with a 3.2-fold greater risk compared with the risk for people without Parkinson disease 8 . In addition to gait disturbances and postural instability, other factors such as postural hypotension, decreased bone mineral density 9, 10 , low vitamin-D levels 11, 12 , dementia 8 , medications 5 , and advanced age 8 further increase the fracture risk for people with Parkinson disease.
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Among the general population, mortality rates for people with hip fractures are reported to be up to 36% greater compared with the rates in non-hip-fracture reference populations 13 . Although it is clear that hip fracture increases mortality in the general population, less is known about the mortality risk after hip fracture in people with Parkinson disease. Hip fractures are common in Parkinson disease and recovery may be complicated by the disease signs and symptoms. Understanding the comparative mortality associated with hip fracture in patients with and without Parkinson disease may help identify those at higher risk of death and determine specific treatment strategies to reduce that risk.
The goal of this study was to investigate mortality rates associated with demographic and clinical risk factors after hip or pelvic (hip/pelvic) fractures in people with Parkinson disease and compare these rates with postfracture mortality rates among those with other medical conditions. We hypothesized that, similar to what has been found in non-Parkinson disease populations, men with Parkinson disease would have a higher mortality after hip/pelvic fracture than women with Parkinson disease, and that mortality would differ according to race/ethnicity. Finally, we expected patients with Parkinson disease to have greater mortality after hip/pelvic fracture than those without Parkinson disease.
Materials and Methods
T his study was approved by the Human Protection Research Office of the Washington University School of Medicine.
Study Population
Beneficiaries with a Medicare part-A or B claim for a hip fracture from 2000 to 2005 were identified from the Medicare Beneficiary Annual Summary File, which contains the date of diagnosis of a hip fracture. In the Medicare Beneficiary Annual Summary File, the diagnosis of hip fracture (hereafter referred to as ''hip/pelvic fracture'') includes any fracture of the proximal part of the femur, acetabulum, or pelvic ring. The International Classification of Diseases, Ninth Revision (ICD-9) codes representing the hip fracture diagnosis in the Medicare Beneficiary Annual Summary File are provided in the Appendix of this article. The Medicare Beneficiary Annual Summary File also contains twenty-one other common diseases contained in Medicare's Chronic Condition Data Warehouse, as well as demographic and vital status data 14 . Using these data, we identified hip/pelvic fracture cases with the following comorbid diagnoses: chronic obstructive pulmonary disease, stroke/transient ischemic attack, diabetes mellitus, ischemic heart disease, osteoporosis, dementia, heart failure, and chronic kidney disease. Medicare outpatient and carrier claims data were used to identify hip/pelvic fracture cases with comorbid Parkinson disease with use of previously published methods 15, 16 .
Demographic and Clinical Data
Race/ethnicity (according to standard Medicare race codes), sex, and date of birth were extracted for each subject. Using information from Medicare's Chronic Condition Data Warehouse contained in the Medicare Beneficiary Annual Summary File, we calculated an age-weighted modified Charlson comorbidity score for each case on the basis of the presence of malignant disease (breast, prostate, endometrial, lung, or colon/rectum), ischemic heart disease, diabetes, chronic obstructive pulmonary disease, stroke/transient ischemic attack, acute myocardial infarction, chronic kidney disease, or heart failure 14 . Using specifications documented by Medicare's Chronic Condition Data Warehouse 17 , we calculated the Charlson comorbidity score on the basis of the presence of a diagnostic claim made in any inpatient or outpatient setting. The time frames used by the Chronic Condition Data Warehouse are (1) the previous calendar year for malignant disease, chronic obstructive pulmonary disease, stroke/transient ischemic attack, and acute myocardial infarction and (2) the previous two years for ischemic heart disease, diabetes, chronic kidney disease, or heart failure. *Native American, unknown, and other were not reported due to small numbers of subjects or race ambiguity; therefore percentages do not equal 100.
Survival Analyses
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mortality of people with hip/pelvic fracture and other common illnesses (dementia, stroke, chronic obstructive pulmonary disease, kidney disease, diabetes, heart failure, ischemic heart disease, and osteoporosis), with hip/pelvic fracture cases without any of these conditions used as the reference group.
Statistical Analyses
Descriptive analyses were performed to compare members of the study population by survival status according to demographic and clinical variables. We used independent t tests to compare means of continuous variables, and we used chi-square tests to compare proportions. Standard methods were used to produce Cox proportional hazard coefficients with 95% confidence intervals (CIs). 
Source of Funding

Results
Subject Demographics
T he demographic characteristics of the study population are summarized in Table I . Our analysis included 1,980,401 individuals who had sustained a hip/pelvic fracture, 131,215 of whom had Parkinson disease. There were more whites and fewer blacks in the Parkinson disease cohort than in the general hip/ pelvic fracture population (p < 0.001). While in both groups, the majority of the patients with a fracture were women, 34. 
Association of Mortality with Medical Condition
The risks of death after hip/pelvic fracture associated with Parkinson disease and other medical conditions are provided in Table III . Among all individuals with hip/pelvic fracture, those with Parkinson disease had a greater risk of death (adjusted [5] [6] [7] , little is known about the factors associated with the post-hip fracture mortality of these individuals. Similar to what has been found in the general population, men with Parkinson disease demonstrated a higher risk of death than women. We also found that mortality varied across race/ethnic categories, with black patients demonstrating a higher and Hispanic patients demonstrating a lower adjusted risk of death compared with white patients. Finally, we demonstrated that people with Parkinson disease had substantially increased postfracture mortality, suggesting a need for aggressive fracture prevention and coordinated postfracture care for people with Parkinson disease.
A major strength of our study is the large sample size. The sample was obtained with use of the Medicare data set, the only population-based U.S. health-care database, which provides substantial power to detect effects on mortality. We were able to achieve complete case follow-up and adjust for multiple factors, including comorbidities. Additionally, we were able to determine mortality differences based on race/ethnicity, which is often underreported in studies of hip fracture. Finally, Medicare data provide a ''real world'' demonstration of the impact of hip/ pelvic fracture on patients with Parkinson disease, in contrast to specialty center studies that report outcomes on a select and often non-representative population. Our study demonstrates the importance of demographic factors in mortality after hip/ pelvic fracture in people with Parkinson disease.
Our findings related to sex are consistent with those of previous studies on mortality following hip fracture in the general population [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . A meta-analysis of mortality following hip fracture surgery demonstrated that men with hip fracture have a higher mortality (pooled HR = of 1.7) than women 27 . The relationship was similar among those with Parkinson disease in our study. It is unclear why men have higher mortality after fracture than women. Previous studies have indicated that men have more comorbidities and more severe comorbidities at the time of fracture 19, 20, [22] [23] [24] , but male sex remained a significant risk factor after adjustment for comorbidities in our study and in others 19, 20, [22] [23] [24] . We were unable to adjust for comorbidity severity, postural instability, gait impairments, or postoperative complications due to the limited data available in this administrative data set.
We are the first, to our knowledge, to report on the association between race/ethnicity and mortality after hip/pelvic fracture in people with Parkinson disease. Studies related to race/ethnicity and mortality after hip/pelvic fracture in the general population have shown conflicting results. Jacobsen et al. 28 used Medicare data from 1984 to 1987 to assess the relationship between sex/race pairings and mortality and reported that mortality rates among white and black men were similar, but black women had a higher mortality rate (22.9 of 1000) than white women (17.2 of 1000). Lu-Yao et al. 21 used Medicare data from 1986 to 1989 and reported that, compared with whites, blacks (adjusted odds ratio [OR] = 1.21, 95% CI = 1.08 to 1.36) and patients with other, unknown, or missing race (adjusted OR = 1.65, 95% CI = 1.41 to 1.94) had higher mortality. Penrod et al. 29 also found that whites were more likely to survive (adjusted OR = 1.74, 95% CI = 1.15 to 2.65) after hip fracture compared with nonwhites. Hannan et al. 30 reported greater six-month mortality in nonwhite patients (24%) compared with white patients (13%); however, this difference was not significant. In contrast, Orces and Alamgir 31 reported higher post-hip fracture mortality in whites compared with blacks and Hispanics among people aged fifty years and older. Our study showed disproportionate mortality among blacks with hip/pelvic fractures and emphasizes the importance of identifying contributors such as health-care quality (both Parkinson diseaserelated and general) and access to and utilization of specialty care.
The reduced mortality found among Hispanics in our data set, however, suggests that socioeconomic factors may not be the only consideration when assessing differences related to race/ethnicity. Our findings are consistent with previous studies that have shown similar differences related to race/ethnicity in all-cause mortality 32 . Compared with whites, blacks demonstrate higher and Hispanics demonstrate lower all-cause mortality 32 . Socioeconomic differences have been implicated in the higher all-cause mortality among blacks 32 ; however, socioeconomic differences may not explain the lower mortality in Hispanics. Hispanics in the U.S. demonstrate lower all-cause mortality compared with non-Hispanics despite lower socioeconomic status and lower rate of health insurance coverage 33, 34 . Three theories to explain this paradox include (1) migration patterns that involve healthier people emigrating to the U.S. and less healthy people returning to their native country; (2) positive cultural differences, such as diet or family structure; and (3) potential data artifacts. Investigators have also found that this may be a feature specific to certain Hispanic subgroups related to national origin or ancestry 34, 35 . We cannot address migration patterns or cultural differences on the basis of the administrative data used in our study.
We found increased mortality associated with Parkinson disease similar to that associated with other conditions, such as dementia, kidney disease, chronic obstructive pulmonary disease, and diabetes. Previous reports specific to Parkinson disease and hip fracture have revealed conflicting findings. Studies published in 1980 and 1990 showed increased mortality following hip fracture in patients with Parkinson disease 36, 37 . These early studies, however, included patients without access to therapies such as deep brain stimulation or aggressive rehabilitation protocols that are in current use. Three recently published studies demonstrated no relationship between Parkinson disease and mortality after hip fracture 25, 29, 38 . However, all were based on relatively small samples, the largest being 2692 subjects 29 . In contrast, our study includes data from 1,980,401 e27(4) 19, 2014 MORTALITY I N U.
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Medicare beneficiaries diagnosed with hip/pelvic fracture, representing the entire elderly hip/pelvic fracture population in the U.S. Our findings suggest that treatment strategies to prevent hip/pelvic fracture and reduce mortality after fracture, particularly in men with Parkinson disease, have the potential to have a substantial public health impact. Most studies have investigated the prevention and treatment of hip fractures in women because of their higher risk for sustaining a hip fracture. Even though women are more likely to sustain a fracture, men are more likely to die after the fracture. Therefore preventative screenings and treatment strategies targeting those at risk for falls and subsequent hip fracture should not be limited to women 25 as they could be potentially life-saving for men. One example is screening for osteoporosis, a risk factor for hip fracture. A statement recently published by the U.S. Preventive Services Task Force provided specific recommendations for osteoporosis screening for women but did not provide a recommendation for men because of insufficient evidence. Given the lack of evidence to support osteoporosis screening for men, it is likely that osteoporosis is underdiagnosed in men. This may be particularly true for men with Parkinson disease, who are more likely to have low bone mineral density compared with healthy controls 9, 39 . In their study of 177 patients newly diagnosed with Parkinson disease, Eng et al. 40 reported that only 11% of men had been previously screened for low bone mineral density compared with 71% of women. Evaluation provided by a physical therapist may also assist in preventing hip/pelvic fracture by identifying, through gait and balance analysis, patients with Parkinson disease who are at risk for falls 41, 42 and by providing treatment to improve gait and postural instability, thus reducing the risk of falls [43] [44] [45] . Coordinated care during the perioperative phase may also help to reduce postfracture mortality of patients with Parkinson disease. Hip/pelvic fracture and the subsequent hospitalization can interrupt complex Parkinson disease medication regimens, reduce efficacy of Parkinson disease medications, and result in a decline in functional mobility [46] [47] [48] [49] . Recent reports highlight the clinical problems faced by patients with Parkinson disease when hospitalized, such as frequent medication errors, infections, confusion, falls, and decubitus ulcers [46] [47] [48] [49] . An interdisciplinary team that is educated in the complexities of Parkinson disease management likely improves outcomes 49 . A small retrospective study of patients with Parkinson disease who underwent a total knee arthroplasty showed that early involvement of a neurologist in the postoperative phase resulted in significantly shorter hospital stays and improved early outcomes 50 , suggesting the need for early neurologic consultation to reduce associated morbidities.
Our study had limitations. There are a number of factors proposed to be related to mortality after hip/pelvic fracture for which we could not account, including prefracture residence 27 , previous level of function 27 , smoking 25 , fracture type 30, 51 , and type of postfracture management. These variables are not contained in the Medicare database 52 . There was also no way to track Parkinson disease or comorbidity severity, which likely remain important uncontrolled confounders. We were not able to validate the accuracy of the diagnosis of Parkinson disease, so conditions mimicking Parkinson disease such as multiple system atrophy may have been misdiagnosed as Parkinson disease and could have influenced the results. However, atypical parkinsonism represent only a small percentage of the total cases presenting with parkinsonism 53, 54 . Minority representation in our data set is lower than that of the U.S. population 55 . The difference in minority representation in our data set, however, is likely influenced by selection of only Medicare beneficiaries who had sustained a hip/pelvic fracture. Whites are more likely to sustain a hip/ pelvic fracture than minority populations 56, 57 , which may explain the discrepancy. The hip fracture variable provided in the Medicare Beneficiary Annual Summary File includes all hip and pelvic fractures that the Centers for Medicare & Medicaid Services (CMS) determined to be relevant to classify as hip fractures. We were unable to identify fracture subtypes, postfracture management, operative procedure, or nonoperative approach provided for each patient. The goal of our current study, however, was to assess the mortality associated with any hip/pelvic fracture in patients with Parkinson disease, a population prone to immobility due to the neurodegenerative disease. Moreover, the inclusion of pelvic fractures, which have lower associated mortality 58, 59 , likely resulted in an underestimate of the true mortality associated with femoral and intertrochanteric fractures in patients with Parkinson disease. Postural instability in Parkinson disease is associated with an increased risk of falls, and, although the distribution of anatomical site cannot be determined from these data, high-energy fractures may be more likely in people with Parkinson disease. The increased mortality that we observed may reflect a greater percentage of high-energy fractures or a greater tendency toward high-energy fractures.
Despite these limitations, our study provides valuable information on the relative mortality of people with Parkinson disease and hip/pelvic fracture. The risk of death after hip/pelvic fracture in people with Parkinson disease varies according to demographic factors. Mortality is increased substantially after hip/pelvic fracture among patients with Parkinson disease. Future studies to understand the factors that contribute to increased mortality after hip/pelvic fracture in patients with Parkinson disease and in subpopulations will help guide treatment strategies to reduce morbidity and mortality in these complex cases.
